全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs812008BAY11-7085 196309-76-9

BAY11-7085 196309-76-9

简要描述:BAY11-7085 196309-76-9
BAY 11-7085 is an irreversible inhibitor of TNFα-induced IκBα phosphorylation with IC50 of 10 μM.

  • 产品型号:abs812008
  • 厂商性质:生产厂家
  • 更新时间:2026-02-25
  • 访  问  量:2448

详细介绍

品牌absinCAS196309-76-9
分子式C13H15NO2S纯度>98%
分子量249.33货号abs812008
规格10mg供货周期现货
主要用途is an irreversible inhibitor of TNFα-ind应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

BAY11-7085 196309-76-9

产品描述
描述

BAY 11-7085 is an irreversible inhibitor of TNFα-induced IκBα phosphorylation with IC50 of 10 μM.

纯度
>98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
BAY 11-7085;BAY-11-7085;BAY 11-7083
外观
white solid
可溶性/溶解性
DMSO : 24.9 mg/mL (100 mM)
Ethanol : 24.9 mg/mL (100 mM)
生物活性
靶点
IκBα phosphorylation
In vitro(体外研究)
BAY 11-7085 inhibits TNFα-induced expression of adhesion molecules E-selectin, VCAM-1, and ICAM-1 by inhibition of NF-κB without detectable cytotoxicity at 10 μM in HUVEC cells. BAY 11-7085 enhances the inhibition of NFkappaB activity by paclitaxel and decreases the viability of cells treated with paclitaxel. Besides, combination of Bay11-7085 and LY294002 leads to synergistic apoptotic effect in PEL cells.
In vivo(体内研究)
BAY 11-7085 inhibits the meningitis-associated increase in NF-κB activity, and results in an improvement of the clinical status of infected rats and a marked attenuation of meningitis-associated CNS complications and meningeal inflammation. BAY 11-7085 increases the efficacy of paclitaxel-induced inhibition of intraabdominal dissemination and production of ascites in athymic nude mice bearing Caov-3 cells.
研究领域
研究领域
Drug DiscoverySmall Molecule DrugLead Compound Discovery
BAY11-7085 196309-76-9温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息